摘要
目的探讨白细胞介素12(IL12)基因转移对弱免疫原性的小鼠B16黑色素瘤细胞生长与转移的影响。方法构建小鼠IL12两个亚单位p40、p35cDNA表达载体;经脂质体LipofectAMIN介导,将两真核表达载体同时导入B16细胞;应用逆转录聚合酶链反应(RTPCR)检测p40、p35mRNA表达;用生物学活性检测法(致分裂激活的活化的小鼠脾细胞增殖)检测IL12分泌;经皮下或静脉接种肿瘤细胞,检测其体内成瘤性及转移性。结果IL12基因转染的B16细胞(B16TIL12)能够表达p40及p35mRNA,分泌有生物活性的IL12;B16TIL12细胞体内成瘤性降低,成瘤延迟,肿瘤生长慢,荷瘤小鼠存活期延长(P<001);肺转移率降低,肺内转移灶明显减少(P<001)。
Objective To study the tumorigenicity and metastasis of poorly immunogenic murine B16 melanoma cells transfected with murine interleukin12 (IL12) gene. Methods Two recombinant vectors containing the full length cDNA of p40 or p35 subunit of IL12 were constructed. They were cotransfected into B16 melanoma cells by LipofectAMIN method. The expressions of p40 and p35 mRNAs were analyzed by means of reverse transcription polymerase chain reaction (RTPCR). The secretion of bioactive IL12 was detected by bioassay (measuring the proliferative response of PMAactivated murine splenocytes). To determine the effects of IL12 secreted by genetically engineered B16 cells (B16TIL12) on tumorigenesis and metastasis, the cells were inoculated s.c. or i.v. into C57BL/6 mice. Results B16TIL12 cells expressed both p40 and p35 mRNAs, also produced bioactive IL12. Only 70% of the mice injected with B16TIL12 cells developed palpable tumors. The emergence of palpable tumors in the mice inoculated with B16TIL12 cells was significantly delayed (P<0.01), the growth rate of the tumors was obviously decreased (P<0.01), and the survival time of tumorbearing mice was prolonged substantially (P<0.01), compared with the control B16 or B16Tneo cells. The incidence of experimental pulmonary metastasis of B16TIL12 cells was inhibited, and the number of pulmonary metastases was reduced markedly, in contrast to the i.v. inoculation of B16 cells (P<0.01). Conclusion Transfection of IL12 gene into B16 cells results in the inhibition of tumorigenesis and in the suppression of experimental pulmonary metastasis.
出处
《中华医学杂志》
CAS
CSCD
北大核心
1998年第8期627-629,共3页
National Medical Journal of China
基金
国家自然科学基金